Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasms”

107,268 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 107,268 results

Not applicableNot Yet RecruitingNCT07792824
What this trial is testing

Witness Project Lung

Who this might be right for
Lung Cancer
Hackensack Meridian Health 400
Not applicableNot Yet RecruitingNCT07700823
What this trial is testing

Two-Point Versus Single-Point Serratus Anterior Plane Block for Post-Thoracoscopic Surgery Analgesia

Who this might be right for
Lung CancerPainVideo-Assisted Thoracoscopic Surgery+1 more
Shiyou Wei 88
Testing effectiveness (Phase 2)Study completedNCT03625323
What this trial is testing

Combination Study With Soluble LAG-3 Fusion Protein Eftilagimod Alpha (IMP321) and Pembrolizumab in Patients With Previously Untreated Unresectable or Metastatic NSCLC, or Recurrent PD-X Refractory NSCLC or With Recurrent or Metastatic HNSCC

Who this might be right for
NSCLCHNSCC
Immutep S.A.S. 187
Large-scale testing (Phase 3)Looking for participantsNCT07393282
What this trial is testing

Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)

Who this might be right for
High Risk Smoldering Multiple Myeloma (HR-SMM)
Regeneron Pharmaceuticals 270
Testing effectiveness (Phase 2)Study completedNCT02311582
What this trial is testing

MK-3475 in Combination With MRI-guided Laser Ablation in Recurrent Malignant Gliomas

Who this might be right for
Malignant Glioma
Washington University School of Medicine 55
Early research (Phase 1)Temporarily pausedNCT06649682
What this trial is testing

68Ga-NYM096/177Lu-NYM096 in Metastatic ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00091182
What this trial is testing

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Extragonadal Germ Cell TumorChildhood Hepatoblastoma+23 more
National Cancer Institute (NCI) 180
Testing effectiveness (Phase 2)WithdrawnNCT05279859
What this trial is testing

Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia
Erasca, Inc.
Not applicableStudy completedNCT01797159
What this trial is testing

Hippocampal Prophylactic Cranial Irradiation for Small Cell Lung Cancer

Who this might be right for
Small-cell Lung CancerSCLCSmall Cell Lung Cancer Limited Stage
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Not applicableStudy completedNCT03627559
What this trial is testing

Early Detection of Anastomotic Leakage by Microdialysis Catheters

Who this might be right for
Pancreatic CancerPancreaticoduodenal; FistulaPancreas; Fistula+1 more
Oslo University Hospital 35
Not applicableUnknownNCT03942380
What this trial is testing

Cell-free Tumor DNA in Head and Neck Cancer Patients

Who this might be right for
Head and Neck CancerHead and Neck NeoplasmsHead and Neck Squamous Cell Carcinoma+24 more
Christian von Buchwald 500
Not applicableLooking for participantsNCT06517979
What this trial is testing

Development and Prospective Validation of a Digital Pathology-based Artificial Intelligence Diagnostic Model for Pan-cancer Lymphatic Metastasis

Who this might be right for
CancerLymphatic Metastasis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 10,000
Early research (Phase 1)UnknownNCT04448379
What this trial is testing

Efficacy and Safety of JMT101 Combined With Afatinib (or Osimertinib) in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Shanghai JMT-Bio Inc. 48
Testing effectiveness (Phase 2)Ended earlyNCT02019979
What this trial is testing

Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC)

Who this might be right for
Non-small Cell Lung Cancer Stage IIIB/IVNon-small Cell Lung Cancer MetastaticNonsquamous Nonsmall Cell Neoplasm of Lung
Beth Israel Medical Center 14
Testing effectiveness (Phase 2)Study completedNCT00428896
What this trial is testing

A Feasibility Study With Iressa in Resistant Cytokeratin-Positive Tumor Cells Circulating in the Blood of Women With Breast Cancer

Who this might be right for
Breast Cancer
University Hospital of Crete 24
Very early researchLooking for participantsNCT05632562
What this trial is testing

Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma

Who this might be right for
High Grade Glioma
University of Alabama at Birmingham 20
Not applicableStudy completedNCT02212262
What this trial is testing

Role of Osteocytes in Myeloma Bone Disease

Who this might be right for
Multiple Myeloma
Attaya Suvannasankha 67
Early research (Phase 1)Study completedNCT00575562
What this trial is testing

Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Kyowa Kirin, Inc. 42
Testing effectiveness (Phase 2)Looking for participantsNCT06599762
What this trial is testing

Evaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid Leukemia

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid LeukemiaMyelodysplastic/Myeloproliferative Neoplasm
University of Manitoba 75
Testing effectiveness (Phase 2)Looking for participantsNCT05844046
What this trial is testing

Sequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-resectable Hepatocellular Carcinoma (HCC) Patients

Who this might be right for
Hepatocellular Carcinoma
Enrico De Toni 83
Next Page